LTR Pharma

Gain a direct line to LTR Pharma leadership.

Be first to know our latest company updates.

Watch exclusive videos accompanying major news.

Annual Reports

Investor Presentations

Announcements

Why Invest

Home

Corporate Governance

Corporate Directory

Board

Scientific Advisory Board

Company

Market Data

Shareholder Services

Shareholders

Montserrat

LTR Pharma Investor Centre

LTR Pharma Limited (ASX:LTP) is excited to announce that SPONTAN® is now accessible through TerryWhite Chemmart's national pharmacy network, marking a significant milestone in expanding patient access. This development enables patients with prescriptions to conveniently fill them at over six hundred pharmacies across Australia, simplifying the process under the TGA's regulatory frameworks. In addition to this expansion, LTR Pharma has introduced new commercial packaging for SPONTAN, tailored for pharmacy distribution, and integration with telehealth platforms for enhanced patient care. The company has successfully integrated with Symbion Pty Ltd, completed key milestones, and is gearing up for a full commercial launch post-regulatory approval. Investors are encouraged to engage with us and ask questions about the expansion, the partnership with Symbion, and the regulatory pathway ahead. Our focus on real-world data collection will provide valuable insights into SPONTAN usage, prescribing patterns, and market dynamics. We look forward to sharing further updates with our investors as we continue to enhance patient access and improve healthcare outcomes. For any inquiries, please contact us at info@ltrpharma.com or visit our website for more information. Stay tuned for more exciting developments from LTR Pharma.

SPONTAN Expands Patient Access via National Pharmacy Network